Status
Conditions
Treatments
About
This is an observational cohort study of clinical efficacy study.The purpose of this topic is to evaluate the efficacy and safety of Modified Liujunzi Decoction based on syndrome differentiation in patients with chronic atrophic gastritis(CAG) after HP eradication.Taking Modified Liujunzi Decoction as the observation group and Weifuchun routine treatment as the control group, so as to provide evidence for the treatment of CAG and reduce the risk of gastric cancer. A total of 284 patients were included. The curative efficacy, symptom score and adverse events will be recorded and analyzed.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
286 participants in 2 patient groups
Loading...
Central trial contact
Qiuyue Huang, doctor
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal